A moderated mediation model confirmed that lower SES indirectly affected future increases in depressive symptom intensity in individuals with, but not without, a MDD family history, via SLC6A4 promoter hypermethylation, which in turn predicted heightened amygdala responsivity. This evidence concerns the gene SLC6A4 and major depressive disorder.